Peloton Therapeutics Overview
- Founded
- 2011
- Status
- Private
- Employees
- 64
- Latest Deal Type
- M&A
- Latest Deal Amount
- $2.35B
Peloton Therapeutics General Information
Description
Peloton Therapeutics Inc is a clinical stage biopharmaceutical company focused on translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. It is focused on targeting HIF-2a, a transcription factor which was thought to be intractable using a small molecule. The company's drug candidate, PT2977, has shown clinical proof of concept in patients with advanced or metastatic clear cell renal cell carcinoma.
Contact Information
Website
www.pelotontherapeutics.com
Formerly Known As
Damascus Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- 2330 Inwood Road
- Suite 226
- Dallas, TX 75235
- United States
+1 (972) 000-0000
Peloton Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 11-Jul-2019 | $2.35B | 00000 | 00.000 | Completed | Clinical Trials - Phase 2 |
| 8. IPO | 26-Apr-2019 | 00000 | 00000 | Cancelled | Clinical Trials - Phase 2 | |
| 7. Later Stage VC (Series E) | 20-Feb-2019 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC (Series D) | 14-Mar-2017 | 000.00 | 00000 | 00000 | Completed | Clinical Trials - Phase 2 |
| 5. Grant | 05-Aug-2016 | 0000 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 4. Later Stage VC (Series C) | 05-Nov-2014 | 000.00 | 000.00 | 00000 | Completed | Clinical Trials - Phase 1 |
| 3. Early Stage VC (Series B) | 18-Dec-2013 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Grant | $11M | $18M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 27-Jul-2011 | $18M | $18M | 0000 | Completed | Startup |
Peloton Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | 00,000,000 | 00.000000 | 00.0 | 00.00 | 00.00 | 00 | 00.00 | 000 |
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 10,080,000 | $0.000100 | $0.1 | $1.25 | $1.25 | 1x | $1.25 | 7.68% |
| Series A | 17,100,000 | $0.000100 | $0.08 | $1 | $1 | 1x | $1 | 13.03% |
Peloton Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Peloton Therapeutics Inc is a clinical stage biopharmaceutical company focused on translating novel scientific insights
Pharmaceuticals
Dallas, TX
64
As of 2019
00000
0.000
0000-00-00
000000&0
00000
000-000
aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000 000000000
Vienna, VA
00
As of 0000
000.00
000000000
000.00
00000000
nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit e
0000 000000000
Cambridge, MA
000
As of 0000
00.000
000000000
00.000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPeloton Therapeutics Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CEL-SCI | Corporate Backed or Acquired | Vienna, VA | 00 | 000.00 | 000000000 | 000.00 |
| 000000000 00000000 | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
| 000000000000 00000 | Venture Capital-Backed | Tokyo, Japan | 0 | 000.00 | 0000000000 0 | 000.00 |
| 000000000 | Venture Capital-Backed | Stevenage, United Kingdom | 000 | 00000 | 00000000 | |
| 0000000 0000000000 | Venture Capital-Backed | Indianapolis, IN | 0 | 000.00 | 0000000000 0 | 000.00 |
Peloton Therapeutics Executive Team (18)
Peloton Therapeutics Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brett Ringle JD | Remeditex Ventures | Board Member | 000 0000 |
Peloton Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial